Seed brings DS-01 gut health products to all Sprouts stores across the U.S.

Microbiome science company Seed Health announced the nationwide retail availability of its clinically validated gut health innovations at Sprouts Farmers Market. Beginning this week, Seed’s flagship DS-01 Daily Synbiotic and the DS-01 14 Day Gut Reset will be available in all 450 Sprouts stores across 24 U.S. states, as well as online via Sprouts.com. The rollout is a pivotal move in Seed Health’s transition from a direct-to-consumer disruptor to a prominent player in the broader health retail ecosystem.

Founded to bridge rigorous microbiome science and public accessibility, Seed Health has seen rapid scaling in recent years. Following a 500% revenue surge over the past 36 months, the launch at Sprouts reflects not only growing demand for gut health solutions but also Seed Health’s intensified focus on omnichannel visibility. The move places its clinically backed probiotic formulations in a retail channel known for engaging health-conscious shoppers and fostering early brand discovery.

Why is Seed Health expanding to natural grocery channels like Sprouts?

Sprouts Farmers Market, headquartered in Phoenix, Arizona, is widely recognized as a leading retailer for natural, organic, and specialty health products. For Seed Health, this channel represents more than shelf space; it is a strategic match for its mission to democratize access to evidence-based wellness solutions.

Seed Health’s initial foray into retail began with Erewhon, the Los Angeles-based luxury grocery chain. There, DS-01 emerged as the top-selling probiotic, setting the tone for rapid acceptance across physical and digital platforms. Within one year, DS-01 achieved top-five status among probiotics on Amazon and quickly ranked among the top 10 products in Target’s Vitamins, Minerals, and Supplements (VMS) category after its launch.

By entering Sprouts at full scale, Seed Health leverages a national platform that connects with a demographic inclined toward plant-based, whole-body wellness solutions. The rollout offers Sprouts customers immediate access to products that are not only premium in formulation but also clinically vetted.

What are the product details for DS-01 and its clinical backing?

Sprouts Farmers Market will stock two core offerings: DS-01 Daily Synbiotic at USD 59.99 and the DS-01 14 Day Gut Reset at USD 29.99. DS-01 is formulated with 24 bacterial strains, engineered for whole-body benefits spanning digestion, skin health, heart function, and immune modulation. What differentiates DS-01 from typical over-the-counter probiotics is its substantiation through human clinical trials.

Most recently, Seed Health presented new research findings at Digestive Disease Week (DDW) 2025, one of the world’s largest gatherings for gastroenterological science. Data from the studies confirmed that DS-01 increases the production of Urolithin A and butyrate—two metabolites crucial for gut barrier function, cellular energy, and healthy aging. The scientific findings add credibility to DS-01’s growing reputation among both consumers and integrative health professionals.

DS-01 14 Day Gut Reset serves a more acute need. Designed for short-term use during travel, stress, or dietary disruptions, it delivers a concentrated dose of DS-01 in a two-week protocol. Clinical validation confirms that the Reset formula helps restore microbiota balance, strengthen the intestinal lining, and support functional gut resilience.

What do Seed Health leaders say about the retail scale-up?

Cathrin Bowtell, Chief Executive Officer of Seed Health, framed the launch as a progression of the brand’s initial success in direct-to-consumer distribution. “Our direct-to-consumer origins set a new standard for science-driven health products while cultivating a profitable business and one of the most loyal customer bases in our category,” Bowtell said. “Launching at Sprouts and expanding our footprint in the natural grocery channel enables us to scale that impact—deepening connections with our community while opening doors for more people to discover Seed for the first time.”

Co-Founder Ara Katz emphasized alignment with Sprouts’ commitment to wellness and environmental integrity. “Our entry into Sprouts helps accelerate our mission to realize the microbiome’s full potential in improving human health—by reaching more people through a retailer that shares our values of wellness, sustainability, and scientific integrity,” Katz noted.

How is the investor community viewing Seed Health’s growth?

While Seed Health is a private company and does not trade on public markets, its aggressive scaling strategy and consistent financial performance have attracted attention from institutional investors and health-focused venture firms. The 500% revenue growth over the last three years, supported by robust DTC performance and strong Amazon and Target metrics, signals a business model that is not only science-led but commercially viable.

Industry watchers note that Seed Health’s hybrid go-to-market strategy—anchored in scientific communication and supported by omnichannel retail—positions the firm to be a category leader in an increasingly competitive space. Competitors in the probiotics sector often struggle to balance marketing claims with clinical validity. Seed’s data-first approach could offer a defensible moat as it explores expansion into adjacent verticals such as skin health, pediatric microbiomes, and women’s health.

What’s next for Seed Health in terms of growth and innovation?

With DS-01 now available in four major retail channels—Sprouts, Target, Amazon, and Erewhon—Seed Health is building the foundation for its next-generation microbiome platform. Upcoming product launches are expected to explore gut-brain signaling, immune pathways, and metabolic modulation. This pipeline is driven by partnerships with academic institutions and internal R&D teams focused on microbiome-targeted therapeutics.

In addition to product innovation, Seed Health is expanding educational outreach, supporting microbiome literacy through clinical content, practitioner partnerships, and its own in-house science communication unit. As awareness of the microbiome’s role in chronic disease and daily wellness continues to grow, Seed Health is positioning itself as both a science authority and an accessible consumer brand.

Analysts expect that if the company maintains its trajectory, it may pursue Series D funding or strategic partnerships to scale internationally, particularly in European and Asia-Pacific markets where probiotic demand is surging.